US frustration with pharmaceutical policy in Australia has grown in recent years, not just in relation to pricing but intellectual property and even biosimilars. …
New Stories
-
One path might be better than the other
June 19, 2018 - - Latest News -
A familiar name returns to lead MSD
June 19, 2018 - - PharmaDispatch Executive -
New studies back Sandoz biosimilars
June 19, 2018 - - Latest News -
MA: SPAs a 'critical element' to ensure access
June 18, 2018 - -
July PBS schedule update
June 18, 2018 - - Latest News -
New appointment for GBMA
June 18, 2018 - - Latest News -
Sirtex accepts $1.9bn takeover bid
June 18, 2018 - - Latest News